Bladder cancer

@article{Kaufman2009BladderC,
  title={Bladder cancer},
  author={D. Kaufman and W. Shipley and A. Feldman},
  journal={The Lancet},
  year={2009},
  volume={374},
  pages={239-249}
}
  • D. Kaufman, W. Shipley, A. Feldman
  • Published 2009
  • Medicine
  • The Lancet
  • Bladder cancer is a heterogeneous disease, with 70% of patients presenting with superficial tumours, which tend to recur but are generally not life threatening, and 30% presenting as muscle-invasive disease associated with a high risk of death from distant metastases. The main presenting symptom of all bladder cancers is painless haematuria, and the diagnosis is established by urinary cytology and transurethral tumour resection. Intravesical treatment is used for carcinoma in situ and other… CONTINUE READING
    211 Citations

    Paper Mentions

    Observational Clinical Trial
    This single-center, cross-sectional survey and sensory examination is conducted to determine the prevalence, sensory characteristics and risk factors of PPSP in patients who underwent… Expand
    ConditionsPain, Post Operative Pain, Surgery
    Bladder cancer.
    • P. Clark
    • Medicine
    • Current opinion in oncology
    • 2007
    Diagnosis and staging of bladder cancer.
    • M. Sun, Q. Trinh
    • Medicine
    • Hematology/oncology clinics of North America
    • 2015
    • 6
    Are we making significant progress in the diagnosis and management of bladder cancer?
    • 1
    Bladder cancer: translating molecular genetic insights into clinical practice.
    • 159
    • Highly Influenced
    Urothelial bladder cancer progression: lessons learned from the bench
    • PDF
    Improving Systemic Chemotherapy for Bladder Cancer
    • 29
    • Highly Influenced
    Low RKIP expression associates with poor prognosis in bladder cancer patients
    • 14
    The Combination of Gemcitabine and Carboplatin in Neoadjuvant Treatment of Bladder Cancer: A Pilot Study
    • Highly Influenced
    • PDF

    References

    SHOWING 1-7 OF 7 REFERENCES
    The role of Ras superfamily proteins in bladder cancer progression.
    • 87
    Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer
    • 121
    Focus on bladder cancer.
    • 272
    The p 53 tumor suppressor gene and nuclear protein : basic science review and relevance in the management of bladder cancer
    • J Urol
    • 2003
    Genetic Testing Information • What is genetic testing? /primer/testing/genetictesting • Genetic Testing Registry: Bladder carcinoma
      National Cancer Institute: Bladder Cancer Treatment (PDQ®)-Patient Version
      • Information & Resources Health Information from MedlinePlus • Encyclopedia: Bladder Cancer